Back to
Cerity Partners LLC
CLYM
Showing 0 of 2 quarters
Position history for
Cerity Partners LLC's holdings in Climb Bio, Inc.
No. Cerity Partners exited its CLYM (Climb Bio) position in Q1 2024. Its Q4 2023 13F listed 13,821 shares worth $37,317. Cerity Partners first reported CLYM in Q4 2023 and held it in 1 quarterly 13F filing.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CLYM: RA Capital Management, L.P.